Jublaint Ingrevia Q2 Results 2025 Highlights: Net Profit Rises by 17.75% & Revenue Up 7.22% YoY

Click and Sign Up to Get Live Updates on Q2 Results 

Jublaint Ingrevia Q2 Results FY26: During Q2 FY26, Jublaint Ingrevia’s profit increased 17.75% YoY, while revenue increased by 7.22% YoY. The company posted robust numbers, with Q2 PAT at ₹69.47 crores and revenue at ₹1,120.73 crores. Jublaint Ingrevia showed its Q2 results on 27th October 2025.  

Jublaint Ingrevia Q2 Results FY26: Extracts of FY25 & FY26

Jublaint Ingrevia Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

• Jublaint Ingrevia clocked Q2 FY26 consolidated revenue of ₹1,120.73 crores vs ₹1,045.24 crores. 
• On the profit front, Jublaint Ingrevia earned a consolidated PAT of ₹69.47 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹59.00 crore.
• According to the consolidated figures, Jublaint Ingrevia’s quarterly PAT increased by 17.75% YoY, while revenue increased by 7.22%.
• Jublaint Ingrevia clocked Q2 FY26 standalone revenue of ₹1,054.18 crores vs ₹1,005.39 crores. 
• On the profit front, Jublaint Ingrevia earned a standalone PAT of ₹44.03 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹60.18 crore.
• According to the standalone figures, Jublaint Ingrevia’s quarterly PAT decreased by 26.84% YoY, while revenue increased by 4.85%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

About Jublaint Ingrevia Limited

Jublaint Ingrevia is a global integrated life sciences and chemical products company that provides solutions to the pharmaceutical, agrochemical, nutrition, and consumer/industrial sectors. The company operates three business segments: Speciality chemicals, Nutrition & Health Solutions, and Life Sciences Chemicals. The company holds a leading position in products like Pyridine and its derivatives and Vitamin B3, and offers manufacturing and development services for other companies.  

Jublaint Ingrevia Share Price Performance

On the opening bell on 28th October 2025, Jublaint Ingrevia shares opened at ₹427.05 per share. However, the initial gains have since eroded, and Jublaint Ingrevia shares are trading at ₹419.85 per share, below the opening price.    

Considering the long-term achievements, Jublaint Ingrevia shares have yielded close to 3.55% returns in the past 6 months, and 1-year returns stand at -5.18%. Over the maximum timeframe, Jublaint Ingrevia shares delivered a 2,235.00% return to investors. 

What Analysts Expect Post Q2 Results?

Following robust Q2 results from Jublaint Ingrevia, analysts expect its share price to rise. According to analysts, Jublaint Ingrevia’s share price could reach ₹510.20 per share in the coming year and, in a downturn, could hit ₹407.20 per share. However, one must ignore stock market volatility and invest in Jublaint Ingrevia’s shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here